NCT02897817View on ClinicalTrials.gov

Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis

CompletedOBSERVATIONAL

Enrollment

471

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Rheumatoid Arthritis

Trial Locations (1)

75007

Nordic Pharma, Paris

Sponsors

Lead Sponsor

Nordic Pharma SAS

All Listed Sponsors

lead

Nordic Pharma SAS

INDUSTRY

NCT02897817 - Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter